Media Mentions: October 2013
September 2013 October 2013 November 2013
Progress toward treatment for dangerous allergies
October 09, 2013
Through the new research, Bilgicer and his group designed a special molecule, called a heterobivalent inhibitor (HBI), which when introduced into a person's bloodstream can, in essence, out-compete allergens like egg or peanut proteins in their race to attach to mast cell receptors.